The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000658314p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
7/05/2026
Date registered
Help: Date registered
3/06/2026
Date last updated
Help: Date last updated
1/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
3/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Feasibility of the Australian Auscultation for Cardiopulmonary Assessment (AUSCA) Patch on Cardiology Patients
Scientific title
Feasibility of the Australian Auscultation for Cardiopulmonary Assessment (AUSCA) Patch on Cardiology Patients
Additional trial identifiers [1] 317214 0
Nil
Universal Trial Number (UTN)
Trial acronym
AUSCA Patch
Related trial records

Health condition
Health condition(s) studied:
Heart Failure 341814 0
Aortic Stenosis 341815 0
Cardiac Disease 341817 0
Condition category
Condition code
Cardiovascular 337885 337885 0 0
Diseases of the vasculature and circulation including the lymphatic system
Cardiovascular 338073 338073 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The AUSCA Patch has been previously developed by a team at UNSW which consists of a more affordable and accurate alternative to stethoscope and ECG machines. The AUSCA patch is a small device that is placed in different positions using double-sided medical tape. The device will be placed in three different positions on the patient’s body using double-sided medical tape: (1) the wrist, (2) the chest, (3) the carotid. The AUSCA Patch will record auscultation waveforms and be stored in a password protected REDCap database that is only accessible to the study team. The AUSCA patch recordings will take altogether an additional 15 minutes. All recordings will be completed during clinic visits at the Heart and Lung clinic and Aortic Stenosis clinic at St Vincent's Hospital.

Participants will undergo three different physiological interventions while having the AUSCA Pach attached to them: (1) inspiratory breath hold, (2) supine to standing manoeuvre and (3) a six-minute walk test. Additionally, all participants will be assessed on their frailty levels based on the Rockwood Clinical Frailty Scale where two independent assessors will complete the assessment.
Intervention code [1] 333979 0
Treatment: Devices
Description of the comparator or control
Control condition will be standard examination by a clinician at St Vincent's Hospital. This includes using a blood pressure and vascular measurement device for blood pressure readings, a digital stethoscope for respiratory readings and echocardiography for aortic stenosis patients.
Control group
Active

Outcomes
Primary outcome [1] 345330 0
Composite Primary Outcome: To evaluate the feasibility, signal quality, and reliability of the AUSCA Patch in continuously recording pulse, respiratory, and electrocardiography (ECG) waveforms under varying physiological loading conditions in patients with cardiac disease.
Timepoint [1] 345330 0
Primary timepoint would be when all participants have completed their clinic visits
Secondary outcome [1] 461313 0
Agreement between haemodynamic waveforms derived from the AUSCA Patch and corresponding MCS device parameters recorded from the device controller.
Timepoint [1] 461313 0
At each monitoring assessment during the study period.

Eligibility
Key inclusion criteria
• Age range: 18 years or older
• Willingness to give written informed consent and willingness to participate in and comply with the study
• For heart failure patients, they need to be classified as New York Heart Association Grade III or IV
• For aortic stenosis patients, patients would need to be classified as having an aortic valve area (AVA) = 1.0 cm2, mean pressure gradient (MPG) = 40 mmHg and must be scheduled to having a transaortic valve replacement (TAVR) intervention.
• For mechanical circulatory supported patient groups, the patient must have a mechanical circulatory support device implanted in them at time of reading and recording
Minimum age
18 Years
Maximum age
90 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
• Patients with a history of a psychological illness or condition such as to interfere with the patient’s ability to understand the requirements of the study
• Patients with an allergy to medical tape as the device requires this to stick to the patient’s body

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
As this study compare outcomes without intervention to intervention, no power calculations have been performed. All data collected will be reported. The effect of exercise, inspiratory breath hold, and 6MWT on individual patients using the AUSCA patch will be compared to their baseline recordings, using paired t-tests. ECG, ultrasound, and digital stethoscope measurements will also be compared against baseline measurements on the auscultation device, using paired t-tests methods.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 29488 0
St Vincent's Hospital (Darlinghurst) - Darlinghurst
Recruitment postcode(s) [1] 45804 0
2010 - Darlinghurst

Funding & Sponsors
Funding source category [1] 321791 0
Government body
Name [1] 321791 0
St Vincent's Centre for Applied Medical Research, Mechanical Circulatory Support Laboratory Funds
Country [1] 321791 0
Australia
Primary sponsor type
Hospital
Name
St Vincent's Hospital Sydney
Address
Country
Australia
Secondary sponsor category [1] 324639 0
University
Name [1] 324639 0
University of New South Wales
Address [1] 324639 0
Country [1] 324639 0
Australia

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320335 0
Bellberry Human Research Ethics Committee A
Ethics committee address [1] 320335 0
Ethics committee country [1] 320335 0
Australia
Date submitted for ethics approval [1] 320335 0
14/05/2026
Approval date [1] 320335 0
Ethics approval number [1] 320335 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150130 0
Prof Christopher Hayward
Address 150130 0
St Vincent's Hospital, 390 Victoria St, Sydney, NSW 2010
Country 150130 0
Australia
Phone 150130 0
+61 28382 6880
Fax 150130 0
Email 150130 0
Contact person for public queries
Name 150131 0
Anne Vuong
Address 150131 0
St Vincent's Hospital, 390 Victoria St, Sydney, NSW 2010
Country 150131 0
Australia
Phone 150131 0
+61 415332611
Fax 150131 0
Email 150131 0
Contact person for scientific queries
Name 150132 0
Anne Vuong
Address 150132 0
St Vincent's Hospital, 390 Victoria St, Sydney, NSW 2010
Country 150132 0
Australia
Phone 150132 0
+61 415332611
Fax 150132 0
Email 150132 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
A finite period of: 10 years
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.